Modulation of inflammatory M1-macrophages phenotype by valvular interstitial cells

Madjid Tagzirt1, Mickael Rosa1, Delphine Corseaux1

  • 1University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, Lille, France.

Abstract

Insights

Profibrotic valvular interstitial cells in aortic valve stenosis reduce matrix metalloproteinase-9 in macrophages, leading to excess collagen. Further research is needed on TGF-β1/PPARγ/MMP-9 roles.

Area of Science:

  • Cardiovascular Biology
  • Cellular Biology
  • Pathology

Background:

  • Aortic valve stenosis is characterized by inflammation, extracellular matrix deposition, and calcification.
  • Inflammatory M1 macrophages promote valvular interstitial cell calcification.
  • Valvular interstitial cells' role in modulating macrophage phenotype is unexplored.

Purpose of the Study:

  • To assess macrophage phenotype in human aortic valve stenosis.
  • To examine gene expression related to fibrosis and inflammation in valves and valvular interstitial cells.
  • To determine if valvular interstitial cells can alter inflammatory macrophage phenotype.

Main Methods:

  • Assessed macrophage phenotype in human aortic valve stenosis and control valves.
  • Examined profibrotic and inflammatory gene expression in valves and valvular interstitial cells.
  • Investigated valvular interstitial cell influence on inflammatory macrophage phenotype.

Main Results:

  • Patients with aortic valve stenosis had higher circulating monocytes and plasma TGF-β1.
  • Aortic valve stenosis valves showed high macrophage infiltration and low MMP-9.
  • Valvular interstitial cells from aortic valve stenosis exhibited a profibrotic phenotype (high TGF-β1, low PPARγ).
  • Valvular interstitial cell-conditioned media from aortic valve stenosis decreased MMP-9 activity and increased collagen in macrophages.

Conclusions:

  • Profibrotic valvular interstitial cells contribute to aortic valve stenosis by reducing MMP-9 in macrophages, causing excessive collagen deposition.
  • Further research is required to elucidate the roles of TGF-β1/PPARγ/MMP-9 in aortic valve stenosis pathogenesis.